CSIMarket
 
Polypid Ltd   (PYPD)
Other Ticker:  
 
 
Price: $5.4900 $0.35 6.841%
Day's High: $5.49 Week Perf: 0.73 %
Day's Low: $ 5.49 30 Day Perf: -19.74 %
Volume (M): 0 52 Wk High: $ 17.25
Volume (M$): $ 2 52 Wk Avg: $8.37
Open: $5.49 52 Wk Low: $3.60



 Market Capitalization (Millions $) 4
 Shares Outstanding (Millions) 1
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 40
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 2

Polypid Ltd
Polypid Ltd is a biopharmaceutical company that specializes in developing and commercializing novel drugs for the prevention and treatment of infectious diseases. The company's focus is on creating innovative, long-acting antibiotic therapies that help overcome antimicrobial resistance and improve patient outcomes. Polypid's proprietary technology platform, known as PolyPid Controlled Release System, allows for the controlled release of drugs at specific target sites, ensuring a prolonged and effective therapy. Their product pipeline includes potential treatments for a range of bacterial infections, including surgical site infections and chronic osteomyelitis. Polypid is dedicated to addressing the global healthcare challenge of drug-resistant infections and improving the quality of life for patients.


   Company Address: 18 Hasivim Street Petach Tikva 495376 NJ
   Company Phone Number: 858-5995   Stock Exchange / Ticker: NASDAQ PYPD
   PYPD is expected to report next financial results on March 30, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Shares

PolyPid Ltd Reclaims Compliance and Resiliently Bounces Back with Improved Share Price

Published Wed, Oct 11 2023 11:00 AM UTC

PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
PETACH TIKVA, Israel, Oct. 11, 2023 - PolyPid Ltd. (Nasdaq: PYPD) (PolyPid or the Company), a late-stage biopharma company aiming to improve surgical outcomes, announced today that it has received a written notice from The Nasdaq Stock Market LLC (Nasdaq) confirming its regained compliance with the min...






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com